In clinical trials, people who continued taking Wegovy maintained their weight loss, whereas those who stopped taking it regained some of the weight they had lost
At Put Your Feet First, we encourage you to come in and share with us your symptoms and the cause of your condition
doi: 10.1158/1078-0432.CCR-21-2241 15 LeiTXuTZhangNZouXKongZWeiCet al
Available from: 16.Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ
A healthcare provider typically evaluates factors such as B12 levels, nutritional needs, and personal health concerns before recommending an appropriate injection schedule
Read this next Incidence of Atherosclerotic CVD Events Higher With Polyendocrine Metabolic Ovarian Syndrome FRIDAY, July 24, 2026 -- Women with polyendocrine metabolic ovarian syndrome (PMOS), previously polycystic ovarian syndrome, have a higher incidence of atherosclerotic